Regulatory coverage
Auto-generated from this app's rule registry (registry/) — not hand-maintained, so it can't silently drift out of sync with what the engine actually checks. 63 rules across 31 source documents. Generated 2026-07-19.
ahpra-evidence.source-reliability — Factor 1 -- Source of the evidence judgmentahpra-evidence.relevance-to-claim-and-population — Factor 2 -- Relevance of the evidence judgmentahpra-evidence.inclusion-no-cherry-picking — Factor 3 -- Inclusion of the evidence judgmentahpra-evidence.study-design-hierarchy — Factor 4 -- Level of the evidence judgmentahpra-evidence.methodological-quality — Factor 5 -- Quality of the evidence judgmentahpra-evidence.clinical-vs-statistical-significance — Factor 6 -- Strength of the evidence judgmentscope-guidelines.work-within-skills-training — Section: Can I perform cosmetic procedures? judgmentscope-guidelines.procedure-specific-authorisation — Section: Can I perform cosmetic procedures? judgmentscope-guidelines.applies-to-non-medical-practitioners — Section: Who do these guidelines apply to? deterministicahpra-social-media.applies-equally — National Law and Advertising guidelines apply equally to social media advertising deterministicahpra-testimonials.clinical-aspects-test — Definition of 'clinical aspects' -- the operational test for what counts as a testimonial patternahpra-testimonials.selective-editing — Selective editing of reviews as independently misleading judgmentahpra-testimonials.advertiser-control-responsibility — Who is responsible for testimonial compliance -- the 'control' test judgmentahpra-code-of-conduct.8.5-advertising — Section 8.5 (Advertising) deterministicacl.s18-misleading-deceptive-conduct — s.18(1) judgmentacl.s29-false-representations — s.29(1) judgmentahpra-guidelines.4.1-misleading-indicators — Section 4.1 (elaborating s.133(1)(a)) patternahpra-guidelines.4.1.4-specialist-title-claims — Section 4.1.4 / 4.1.4.a (Titles and claims about registration, competence and qualifications) judgmentahpra-guidelines.4.2-gifts-inducements — Section 4.2 (elaborating s.133(1)(b)) patternahpra-guidelines.4.3-testimonials — Section 4.3 / 4.3.1 (elaborating s.133(1)(c)) patternahpra-guidelines.4.4-unreasonable-expectation-language — Section 4.4 (elaborating s.133(1)(d)) patternahpra-guidelines.4.5-urgency-scarcity — Section 4.5 (elaborating s.133(1)(e)) patternahpra-guidelines.4.5-incentives-outweighing-risk — Section 4.5 (elaborating s.133(1)(e)) judgmentahpra-cosmetic-2025.minimising-risk-language — Section: Risk, recovery, and idealising higher risk cosmetic procedures patternahpra-cosmetic-2025.idealising-outcome-language — Sections: Body image and promotion for wellbeing; Realistic expectations of outcomes; Professional expectations (trivialising) patternahpra-cosmetic-2025.vulnerable-persons — Section 13 (Good practice in advertising higher risk cosmetic procedures) -- vulnerable individuals judgmentahpra-cosmetic-2025.trivialising-language — Section 13 (Good practice in advertising higher risk cosmetic procedures) -- trivialising terms patternahpra-cosmetic-2025.testimonial-interaction — Section 13 (Good practice in advertising higher risk cosmetic procedures) -- Testimonials judgmentahpra-cosmetic-2025.social-media-influencers — Section 13 (Good practice in advertising higher risk cosmetic procedures) -- Social media influencers and ambassadors judgmentahpra-cosmetic-2025.before-after-images — Section 13 (Good practice in advertising higher risk cosmetic procedures) -- Use of images including 'before and after' images judgmentahpra-s116.claims-as-to-registration — s.116(1) deterministicHealth Practitioner Regulation National Law, s.118 (Claims by persons as to specialist registration)
ahpra-s118.claims-as-to-specialist-registration — s.118(1) deterministicahpra-s133.1a — s.133(1)(a) judgmentahpra-s133.1b — s.133(1)(b) patternahpra-s133.1c — s.133(1)(c) patternahpra-s133.1d — s.133(1)(d) judgmentahpra-s133.1e — s.133(1)(e) judgmentms-cosmetic-surgery.registration-disclosure — Good practice in cosmetic surgery advertising -- mandatory registration disclosure deterministicms-cosmetic-surgery.informed-consent-patient-images — Good practice in cosmetic surgery advertising -- patient image consent process judgmentms-cosmetic-surgery.entertainment-trivialisation — Good practice in cosmetic surgery advertising -- trivialising cosmetic surgery via entertainment framing judgmentpoisons-standard.botulinum-toxin-schedule4 — Schedule 4 -- botulinum toxin (cosmetic injectables, general statement) deterministicpoisons-standard.compounded-glp1-advertising-ban — Sections: Supplying compounded medicines (Extemporaneously compounded medicines); Requirements for specific compounding activities and products (GLP-1); Advertising compounded medicines deterministicpoisons-standard.glutathione-status — ARTG registration status of glutathione as a therapeutic ingredient deterministictga-code.restricted-prohibited-representations — Prohibited representations (TG Regulations 1990, referenced via Advertising Code Part 8) deterministicpoisons-standard.nad-nadh-nmn-status — ARTG/permitted-ingredient status of NAD, NAD+, NADH, NMN deterministictga-injectables.euphemism-indirect-reference — Guidance on indirect/euphemistic references to prescription-only cosmetic injectables judgmenttga-injectables.off-label-indication — Off-label / non-ARTG-accepted indication advertising deterministictga-injectables.hyaluronic-acid-filler-schedule4 — Hyaluronic acid dermal filler scheduling (worked example: Profhilo) deterministictga-injectables.prp-monothreads-out-of-scope — Scope boundary: PRP, bio-remodellers, monothreads judgmenttga-boundary.service-vs-good — Boundary doctrine -- when health service advertising becomes therapeutic good advertising judgmentpoisons-standard.semaglutide-glp1-schedule4 — Schedule 4 -- GLP-1 receptor agonists (semaglutide, tirzepatide, dulaglutide, and derivatives) deterministictga-enforcement.recent-cosmetic-injectable-actions — Published enforcement outcomes -- cosmetic injectables, evidencing active priority status deterministictga-enforcement.compliance-priorities-2026-2027 — Five compliance principles and priority focus areas, effective 1 Jan 2026 - 31 Dec 2027 deterministictga-prescription-infusion.dtca-prohibition — Therapeutic Goods Act 1989 ss.42DL(10), 42DLB(7) deterministictga-listed-medicines.permitted-indication-scope — Scope of a 'permitted indication' -- listing status vs. advertising compliance judgmenttga-devices.off-label-advertising-ban — s.41FN(5), s.41ML, s.41MLB of the Therapeutic Goods Act 1989 deterministictga-code.s11-scientific-clinical-representations — Section 11 (Scientific or clinical representations) judgmenttga-code.s12-advertising-to-children — Section 12 (Advertising to children) deterministictga-code.s8-accuracy — Section 8 (Accuracy) judgmenttga-code.s9-safe-proper-use — Section 9 (Safe and proper use) patterntga-code.s24-testimonial-relevant-person — Section 24(4) (Testimonials -- prohibited sources) patterntga-code.s24-health-professional-endorsement — Section 24 (Endorsements) judgmenttga-cosmetic-therapeutic-boundary.therapeutic-use-definition — Therapeutic Goods Act 1989 s.3; TGA cosmetic/therapeutic boundary guidance judgment